Percutaneous pulmonary arterial denervation for treament of chronic heart failure with secondary pulmonary hypertension

Trial Profile

Percutaneous pulmonary arterial denervation for treament of chronic heart failure with secondary pulmonary hypertension

Not yet recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 10 Dec 2012

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Heart failure; Pulmonary hypertension
  • Focus Biomarker; Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 10 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top